Dr. Rudrapatna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1111 Duff Ave
Ames, IA 50010Phone+1 515-239-4401Fax+1 515-239-4791
Education & Training
University of Utah HealthFellowship, Hematology and Medical Oncology, 2008 - 2011- University of Utah HealthResidency, Internal Medicine, 2005 - 2008
Dr. DY Patil Medical CollegeClass of 1998
Certifications & Licensure
IA State Medical License 2015 - 2026
MN State Medical License 2011 - 2019
UT State Medical License 2006 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy Start of enrollment: 2011 Aug 01
- HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma Start of enrollment: 2012 Aug 01
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Publications & Presentations
PubMed
- 21 citationsNutrition status and health-related quality of life among outpatients with advanced head and neck cancerUrvashi Mulasi, David M. Vock, Harriët Jager-Wittenaar, Levi Teigen, Adam J. Kuchnia
Nutrition in Clinical Practice. 2020-12-01 - 12 citationsMalnutrition Identified by the Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition Consensus Criteria and Other Bedside Tools ...Urvashi Mulasi, David M Vock, Adam J Kuchnia, Gautam Jha, Naomi Fujioka
JPEN. Journal of Parenteral and Enteral Nutrition. 2018-01-01 - 2 citationsPhase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapy.Venkatesh K. Rudrapatna, Kimberly A. Morley, Kenneth M. Boucher, Andrew S. Pierson, Christian T. Shull
Leukemia Research. 2015-08-01
Press Mentions
Impact of Sequencing Targeted Therapies with High-Dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients with Metastatic Renal Cell Carcinoma from an on-Going Observational IL-2 Clinical Trial: PROCLAIM SMFebruary 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
